Signal active
Organization
Contact Information
Overview
NeuSpera, formerly known as Vivonda Medical, is developing injectable neuromodulation devices, so called “electroceuticals,” using licensed mid-field powering technology.
About
Health Care, Biopharma, Medical Device
2013
11-50
Headquarters locations
San Jose, California, United States, North America
Social
Profile Resume
NeuSpera Medical headquartered in United States, North America, operates in the Health Care, Biopharma, Medical Device sector. The company focuses on Health Care and has secured $9.7B in funding across 72 round(s). With a team of 11-50 employees, NeuSpera Medical is actively contributing to advancements in Health Care. Their latest funding round, Venture Round - NeuSpera Medical, raised $8.9M. Discover more about their projects, partnerships, and impact on our platform.
Funding Rounds
6
0
0
$134.9M
Details
4
NeuSpera Medical has raised a total of $134.9M in funding over 4 rounds.
Announcement date | Transaction name | Number of Investors | Money raised | Lead Investor |
---|---|---|---|---|
2018 | Early Stage Venture | 26.0M | ||
2019 | Early Stage Venture | 12.0M | ||
2021 | Late Stage Venture | 65.0M | ||
2024 | Late Stage Venture | 23.0M |
Investors
NeuSpera Medical is funded by 29 investors.
Investor Name | Lead Investor | Funding Round | Partners |
---|---|---|---|
NeuSpera Medical | - | FUNDING ROUND - NeuSpera Medical | 23.0M |
Treo Ventures | - | FUNDING ROUND - Treo Ventures | 23.0M |
NeuSpera Medical | - | FUNDING ROUND - NeuSpera Medical | 23.0M |
Action Potential Venture Capital | - | FUNDING ROUND - Action Potential Venture Capital | 23.0M |
Recent Activity
News
Aug 20, 2024
Medical Product Outsourcing - Neuspera Medical Closes Series D Funding Round
News
Jul 27, 2024
Morningstar - Neuspera Medical, Inc. Reaches Significant Milestone: Final Patient Has Completed Primary Endpoint Visit in the SANS-UUI Pivotal Clinical Trial
News
Jul 20, 2024
FinSMEs - Neuspera Medical Raises $23M in Series D Financing
News
Jul 20, 2024
MassDevice - Neuromod developer Neuspera Medical raises $23M in Series D
News
Jul 20, 2024
PR Newswire - Neuspera Medical Raises $23 Million in Series D Financing
News
Jul 20, 2024
Yahoo Finance - Neuspera Medical secures $23m for SNM system